Skip to main content

Table 1 Participant timeline. The time points are explained in the main manuscript (see 12)

From: Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial

 

Study period

 

Enrolment

Allocation

Intervention

Post-intervention

Time point/assessment

 

T0/A0

T1/A1

T2/A2

T3/A3

Study participation

     

 Eligibility screen

X

    

 Informed consent

X

    

 Allocation

 

X

   

Clinical data collection

     

 Evaluation of adverse events (AE)

 

X

X

X

X

 Duration index hospital stay

  

X

  

 Duration stays in different wards

  

X

  

 Transfer to external hospitals

  

X

  

 Transfer to rehabilitation facilities

  

X

  

 MPI (geriatric assessment)

X

 

X

X

X

 Health literacy

 

X

X

X

X

 Quality of life/depression/health status/self-efficacy

 

X

X

X

X

 Medication plan

 

X

X

X

X

 Minimal Nutritional Assessment

 

X

X

X

X

 Mobility tests

 

X

X

X

X

 Patient orientation

 

X

 

X

X

 Personal goals/self-management/personal therapy burden

  

X

X

X

 Photo documentation drugs

   

X

X

 Number of rehospitalizations

   

X

X

 Health economic evaluation

    

X

 Utilization of rehabilitation services

    

X

 Length of stay in inpatient facilities

    

X

 Death

    

X

Laboratory data collection

     

 24-h collection urine

 

X

X

X

X

 Clinical chemistry

 

X

X

X

X